Page last updated: 2024-08-21

methoxyhydroxyphenylglycol and Parkinson Disease

methoxyhydroxyphenylglycol has been researched along with Parkinson Disease in 66 studies

Research

Studies (66)

Timeframe	Studies, this research(%)	All Research%
pre-1990	33 (50.00)	18.7374
1990's	14 (21.21)	18.2507
2000's	9 (13.64)	29.6817
2010's	9 (13.64)	24.3611
2020's	1 (1.52)	2.80

Authors

Authors	Studies
Goldstein, DS; Holmes, C; Lamotte, G; Lenka, A; Sharabi, Y; Sullivan, P	1
Aerts, T; De Deyn, PP; Fransen, E; Gerritsen, MJ; Spikman, JM; Van Dam, D; van der Zee, S; van Laar, T; Vermeiren, Y	1
Bloem, BR; Herbert, MK; Kuiperij, H; Verbeek, MM	1
Goldstein, DS; Holmes, C; Kopin, IJ; Sharabi, Y	1
Goldstein, DS; Holmes, C; Kopin, IJ; Mash, DC; Sharabi, Y; Sullivan, P	1
Andersen, ML; Aurich, MF; da Cunha, C; Lima, MM; Noseda, AC; Rodrigues, LS; Targa, AD; Tufik, S	1
Bentho, O; Eldadah, BA; Goldstein, DS; Grossman, E; Holmes, C; Imrich, R; Pechnik, S; Sharabi, Y	1
Goldstein, DS; Holmes, C; Imrich, R; Pechnik, S; Sharabi, Y	1
Granérus, AK; Mårtensson, B; Pålhagen, S; Qi, H; Svenningsson, P; Wålinder, J	1
Adar, L; Goren, T; Sasson, N; Weiss, YM	1
Constantinescu, R; Nyhlén, J; Zetterberg, H	1
Gu, L; Sun, L; Wang, S; Yang, H; Yuan, J; Zhang, H; Zhu, J	1
Brentzel, S; Eisenhofer, G; Goldstein, DS; Holmes, C; Sharabi, Y	1
Albin, RL; Feeley Kearney, JA	1
Abdo, WF; Bloem, BR; De Jong, D; Hendriks, JC; Horstink, MW; Kremer, BP; Verbeek, MM	1
Abdo, WF; Bloem, BR; Esselink, RA; Van Geel, WJ; Verbeek, MM	1
Agari, T; Borlongan, CV; Date, I; Kondo, A; Kuramoto, S; Matsui, T; Miyoshi, Y; Shingo, T; Yasuhara, T	1
Mayeux, R	1
Calne, DB; Ebert, MH; Eisler, T; Kopin, IJ; Krebs, H; Lake, CR; Murphy, DL; Nelson, R; Teräväinen, H; Weise, V; Whetzel, N	1
Edwards, DJ; Rizk, M; Spiker, DG	1
Bistolaki, E; Hadjikonstantinou, M; Markianos, M	1
Cote, L; Mayeux, R; Stern, Y; Williams, JB	1
Aguado, EG; de Yebenes, JG; Mena, MA	1
Côté, L; Mayeux, R; Stern, Y	1
Mann, DM	1
Kuroda, H; Nukina, I; Ogawa, N; Ota, Z; Yamamoto, M	1
Kaplan, RD; Mann, JJ; Neophytides, A; Stanley, M; Sweeney, J	1
Ahlskog, JE; Low, PA; Nickander, KK; O'Brien, JF; Tyce, GM; Uitti, RJ	1
Brashear, A; Butler, IJ; Dobyns, WB; Farlow, MR; Kasarskis, EJ	1
Ahlskog, JE; Kokmen, E; O'Brien, JF; Petersen, RC; Tyce, GM; Uitti, RJ	1
Bowers, MB	1
Brashear, A; Butler, IJ; Dobyns, WB; Farlow, MR; Hyland, K	1
Ekman, R; Fall, PA; Granérus, AK; Thorell, LH; Wålinder, J	1
Hamamoto, M; Katayama, Y; Miyazaki, T; Nagayama, H; Nito, C; Otsubo, K; Terashi, A; Ueda, M	1
Iacono, RP; Nahab, FB; Nahab, FH	1
Bruce, S; Cannon, RO; Goldstein, DS; Holmes, C; Li, ST; Metman, LV	1
Mizuno, Y	1
Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM	1
de Vries, JA; Fremouw-Ottevangers, DC; Muskiet, FA; Nagel, GT; Wolthers, BG	1
Markianos, ES; Rüther, E	1
Birkmayer, W; Riederer, P; Seemann, D; Wuketich, S	1
Blandini, F; Bono, G; Martignoni, E; Nappi, G; Pacchetti, C; Petraglia, F	1
Benoit, B; Grimes, D; Lach, B; Minkiewicz-Janda, A	1
Lindvall, B; Olsson, JE	1
Kuhn, W; Przuntek, H	1
Bankiewicz, KS; Kopin, IJ; Mefford, I; Oldfield, EH; Plunkett, RJ	1
Matsushima, E; Nishikawa, S; Sano, K; Takahashi, K; Takao, T; Urakami, K	1
Blank, CL; Ikarashi, Y; Inoue, HK; Itoh, K; Maruyama, Y; Satoh, H	1
Cote, L; Dyrenfurth, I; Frantz, A; Mayeux, R; Stern, Y; Williams, JB	1
Cote, L; Mayeux, R; Sano, M; Stern, Y; Williams, JB	2
Andersen, K; Balldin, J; Gottfries, CG; Granérus, AK; Modigh, K; Svennerholm, L; Wallin, A	1
Sharpless, NS; Thal, LJ; Wolfson, LI	1
Araki, H; Kondo, T; Muramoto, S; Narabayashi, H; Nishi, K; Takubo, H	1
Kraus, P; Kuhn, W; Przuntek, H	1
Backlund, EO; Granberg, PO; Hamberger, B; Knutsson, E; Mårtensson, A; Olson, L; Sedvall, G; Seiger, A	1
Barchas, JD; Berger, PA; Faull, KF; Stahl, SM	1
Burns, RS; Ebert, MH; Kopin, IJ; LeWitt, PA; Pakkenberg, H	1
Gibson, CJ; Growdon, JH; Logue, M	1
Ahlskog, JE; Carmichael, SW; Chritton, SL; Kelly, PJ; Stoddard, SL; Tyce, GM; van Heerden, JA; Yaksh, TL	1
Ogawa, N; Ujike, H; Yamamoto, M	1
Cash, R; Dennis, T; Javoy-Agid, F; L'Heureux, R; Raisman, R; Scatton, B	1
Juujärvi, KK; Myllylä, VV; Turkka, JT	1
Chase, TN; Gordon, EK; Ng, LK	1
Garelis, E; Lal, S; Sourkes, TL; Young, SN	1
Dinapoli, RP; Muenter, MD; Sharpless, NS; Tyce, GM	1

Reviews

4 review(s) available for methoxyhydroxyphenylglycol and Parkinson Disease

Article	Year
Problems associated with fluid biomarkers for Parkinson's disease. Biomarkers in medicine, 2010, Volume: 4, Issue:5 Topics: alpha-Synuclein; Amyloid beta-Peptides; Biomarkers; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Interleukins; Intracellular Signaling Peptides and Proteins; Methoxyhydroxyphenylglycol; Oncogene Proteins; Parkinson Disease; Peptide Fragments; Protein Deglycase DJ-1; tau Proteins; Uric Acid	2010
Behavioral manifestations of movement disorders. Parkinson's and Huntington's disease. Neurologic clinics, 1984, Volume: 2, Issue:3 Topics: Adult; Aged; Dementia; Depression; Depressive Disorder; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Intelligence; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Personality	1984
The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system. Mechanisms of ageing and development, 1983, Volume: 23, Issue:1 Topics: Adult; Aged; Aging; Alzheimer Disease; Cerebral Palsy; Cytoskeleton; Dementia; Down Syndrome; Humans; Locus Coeruleus; Melanins; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease	1983
Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies. Brain research, 1974, Oct-11, Volume: 79, Issue:1 Topics: Animals; Biological Transport, Active; Brain; Cats; Cerebral Ventricles; Cerebrospinal Fluid; Choroid Plexus; Dihydroxyphenylalanine; Dogs; Dopamine; Fenclonine; Glycols; Haplorhini; Homovanillic Acid; Humans; Hydrocephalus; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Parkinson Disease; Phenylacetates; Probenecid; Serotonin; Spinal Cord; Spinal Cord Injuries; Tryptophan	1974

Trials

4 trial(s) available for methoxyhydroxyphenylglycol and Parkinson Disease

Article	Year
Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline. Journal of clinical pharmacology, 2010, Volume: 50, Issue:12 Topics: Adult; Aged; Algorithms; Contraindications; Diet; Dose-Response Relationship, Drug; Double-Blind Method; Drug Labeling; Female; Humans; Hypertension; Indans; Isoenzymes; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Tyramine; United States	2010
Deprenyl in Parkinson disease. Neurology, 1981, Volume: 31, Issue:1 Topics: Adult; Aged; Carbidopa; Dopamine; Double-Blind Method; Drug Combinations; Epinephrine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Phenethylamines; Selegiline	1981
A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena. Acta neurologica Scandinavica, 1987, Volume: 76, Issue:3 Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Electroconvulsive Therapy; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease	1987
Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. Journal of neurosurgery, 1985, Volume: 62, Issue:2 Topics: Adrenal Medulla; Caudate Nucleus; Clinical Trials as Topic; Corpus Striatum; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuronal Plasticity; Parkinson Disease; Receptors, Dopamine; Stereotaxic Techniques; Synaptic Transmission; Transplantation, Autologous	1985

Other Studies

58 other study(ies) available for methoxyhydroxyphenylglycol and Parkinson Disease

Article	Year
Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies. Journal of neurochemistry, 2021, Volume: 158, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Cohort Studies; Dopamine; Dopaminergic Neurons; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Neurons; Norepinephrine; Parkinson Disease; Pure Autonomic Failure; Retrospective Studies; Synucleinopathies	2021
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease. Journal of Parkinson's disease, 2018, Volume: 8, Issue:1 Topics: Aged; Biogenic Monoamines; Biomarkers; Cognition Disorders; Cognitive Dysfunction; Diagnosis, Differential; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lewy Body Disease; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Retrospective Studies	2018
Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controls. Journal of neurology, 2013, Volume: 260, Issue:12 Topics: Aged; Cerebrovascular Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary	2013
Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2015, Volume: 25, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Biomarkers; Case-Control Studies; Comorbidity; Cross-Sectional Studies; Diagnosis, Differential; Dopamine; Female; Fluorine Radioisotopes; Humans; Hypotension, Orthostatic; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Parkinson Disease; Sensitivity and Specificity; Synaptic Vesicles	2015
Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy. Parkinsonism & related disorders, 2015, Volume: 21, Issue:6 Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Aldehyde Dehydrogenase; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Frontal Lobe; Humans; Male; Methoxyhydroxyphenylglycol; Multiple System Atrophy; Neurons; Norepinephrine; Parkinson Disease	2015
Unraveling a new circuitry for sleep regulation in Parkinson's disease. Neuropharmacology, 2016, Volume: 108 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Male; Methoxyhydroxyphenylglycol; Nerve Net; Parkinson Disease; Pars Compacta; Rats; Rats, Wistar; Sleep Stages	2016
Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension. Parkinsonism & related disorders, 2009, Volume: 15, Issue:2 Topics: Adrenergic beta-Agonists; Aged; Autonomic Nervous System Diseases; Blood Pressure; Dopamine; Female; Heart; Hemodynamics; Humans; Hypotension, Orthostatic; Isoproterenol; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Statistics, Nonparametric; Sympathectomy; Sympathomimetics; Tyramine	2009
Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension. Movement disorders : official journal of the Movement Disorder Society, 2008, Sep-15, Volume: 23, Issue:12 Topics: Aged; Blood Pressure; Bradycardia; Cholinesterase Inhibitors; Edrophonium; Epinephrine; Female; Glucagon; Humans; Hypotension, Orthostatic; Isoproterenol; Male; Methoxyhydroxyphenylglycol; Microdialysis; Middle Aged; Muscle, Skeletal; Norepinephrine; Parkinson Disease; Pure Autonomic Failure; Tyramine; Yohimbine	2008
Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression. Journal of neurology, 2010, Volume: 257, Issue:4 Topics: Aged; Analysis of Variance; Biogenic Monoamines; Brain-Derived Neurotrophic Factor; Corticosterone; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Interleukin-6; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Radioimmunoassay	2010
N-acetylcysteine protects against apoptosis through modulation of group I metabotropic glutamate receptor activity. PloS one, 2012, Volume: 7, Issue:3 Topics: Acetylcysteine; Animals; Apoptosis; Cell Line; Cell Survival; Disease Models, Animal; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Free Radical Scavengers; Methoxyhydroxyphenylglycol; Oxidation-Reduction; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Metabotropic Glutamate; Staurosporine	2012
Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurology, 2003, Apr-22, Volume: 60, Issue:8 Topics: Adrenal Medulla; Aged; Autonomic Nervous System Diseases; Catechols; Epinephrine; Female; Heart Conduction System; Humans; Male; Metanephrine; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Normetanephrine; Parkinson Disease; Shy-Drager Syndrome; Supine Position; Sympathetic Nervous System	2003
mGluRs: a target for pharmacotherapy in Parkinson disease. Experimental neurology, 2003, Volume: 184 Suppl 1 Topics: Amino Acids, Dicarboxylic; Animals; Autoradiography; Basal Ganglia; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Glucose; Immunohistochemistry; Methoxyhydroxyphenylglycol; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Rats; Receptors, Metabotropic Glutamate	2003
Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:5 Topics: Adult; Aged; Benzamides; Brain; Diagnosis, Differential; Electromyography; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Iodine Radioisotopes; Lactic Acid; Male; Methoxyhydroxyphenylglycol; Multiple System Atrophy; NAD; Parkinson Disease; Pyrrolidines; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2004
CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease. Neurobiology of aging, 2007, Volume: 28, Issue:5 Topics: Adult; Aged; Biomarkers; Follow-Up Studies; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Neurofilament Proteins; Parkinson Disease; Retrospective Studies; tau Proteins	2007
Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: behavioral and histological analyses. Brain research, 2008, Apr-08, Volume: 1203 Topics: Adrenergic Agents; Analysis of Variance; Animals; Behavior, Animal; Dioxolanes; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Globus Pallidus; Methoxyhydroxyphenylglycol; Motor Activity; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Purines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase	2008
Effects of L-DOPA on the excretion of alcoholic metabolites of catecholamines and trace amines in rat and human urine. Biochemical medicine, 1981, Volume: 25, Issue:2 Topics: 3-Methoxy-4-hydroxyphenylethanol; Amines; Animals; Dopamine; Gas Chromatography-Mass Spectrometry; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Parkinson Disease; Phenylethyl Alcohol; Rats	1981
Urinary noradrenaline and serotonin metabolites in drug-free Parkinson patients and the effect of L-dopa treatment. Acta neurologica Scandinavica, 1982, Volume: 66, Issue:2 Topics: Aged; Cyclic AMP; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Parkinson Disease; Serotonin	1982
Altered serotonin metabolism in depressed patients with parkinson's disease. Neurology, 1984, Volume: 34, Issue:5 Topics: Aged; Depression; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Parkinson Disease; Serotonin	1984
Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method. Acta neurologica Scandinavica, 1984, Volume: 69, Issue:4 Topics: 3,4-Dihydroxyphenylacetic Acid; Alzheimer Disease; Chromatography, High Pressure Liquid; Depression; Dihydroxyphenylalanine; Electrochemistry; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Parkinson Disease; Phenylacetates; Subarachnoid Hemorrhage; Tryptophan; Tyrosine	1984
Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism. Archives of neurology, 1984, Volume: 41, Issue:10 Topics: Aged; Arousal; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Norepinephrine; Parkinson Disease; Psychological Tests; Reaction Time	1984
Improvement in freezing phenomenon of Parkinson's disease after DL-threo-3, 4-dihydroxyphenylserine. Acta medica Okayama, 1984, Volume: 38, Issue:3 Topics: Aged; Benserazide; Droxidopa; Gait; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Parkinson Disease; Serine	1984
Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1983, Volume: 46, Issue:10 Topics: Blood Platelets; Cognition; Glycols; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Motor Skills; Parkinson Disease; Phenylacetates	1983
Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease. Neurology, 1996, Volume: 46, Issue:3 Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Cysteinyldopa; Humans; Levodopa; Malondialdehyde; Methoxyhydroxyphenylglycol; Middle Aged; Oxidative Stress; Parkinson Disease; Selegiline	1996
Variable phenotype of rapid-onset dystonia-parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:2 Topics: Adolescent; Adult; Dopamine; Dystonia; Female; Follow-Up Studies; Genetic Carrier Screening; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurologic Examination; Parkinson Disease; Pedigree; Phenotype	1996
Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases. Journal of the neurological sciences, 1996, Volume: 136, Issue:1-2 Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Alzheimer Disease; Blood Platelets; Catecholamines; Epinephrine; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Norepinephrine; Parkinson Disease	1996
Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences, 1996,Fall, Volume: 8, Issue:4 Topics: Adult; Aged; Depressive Disorder; Female; Homovanillic Acid; Humans; Kidney Failure, Chronic; Levodopa; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Psychotic Disorders; Renal Dialysis	1996
Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism. Annals of neurology, 1998, Volume: 43, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Biomarkers; Deglutition Disorders; Dopamine; Dysarthria; Dystonia; Female; Genetic Carrier Screening; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Parkinson Disease; Pedigree; Serotonin; Time Factors	1998
ECT in Parkinson's disease. Changes in motor symptoms, monoamine metabolites and neuropeptides. Journal of neural transmission. Parkinson's disease and dementia section, 1995, Volume: 10, Issue:2-3 Topics: Aged; Aged, 80 and over; Biogenic Monoamines; Electroconvulsive Therapy; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Neuropeptides; Parkinson Disease; Time Factors	1995
Susceptibility to neuroleptic malignant syndrome in Parkinson's disease. Neurology, 1999, Mar-10, Volume: 52, Issue:4 Topics: Aged; Aged, 80 and over; Disease Susceptibility; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Neuroleptic Malignant Syndrome; Parkinson Disease; Prospective Studies; Risk Factors	1999
Serotonergic decompensation in the akinetic expression of Parkinson's disease. The International journal of neuroscience, 2000, Volume: 101, Issue:1-4 Topics: Brain; Chromatography, High Pressure Liquid; Dopamine; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Levodopa; Methoxyhydroxyphenylglycol; Norepinephrine; Parkinson Disease; Serotonin; Synaptic Transmission	2000
Cardiac sympathetic denervation in Parkinson disease. Annals of internal medicine, 2000, Sep-05, Volume: 133, Issue:5 Topics: Adult; Aged; Blood Pressure; Brain; Cardiac Catheterization; Diagnosis, Differential; Dopamine; Female; Fluorine Radioisotopes; Heart; Heart Rate; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Myocardium; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Tritium; Valsalva Maneuver	2000
[Cerebrospinal fluid methoxyhydroxy-phenylene glycol in Parkinson's disease and spinocerebellar degeneration (author's transl)]. No to shinkei = Brain and nerve, 1979, Volume: 31, Issue:3 Topics: Cerebellar Diseases; Glycols; Humans; Methoxyhydroxyphenylglycol; Nerve Degeneration; Parkinson Disease; Spinal Cord Diseases	1979
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders. Journal of neurology, neurosurgery, and psychiatry, 1977, Volume: 40, Issue:12 Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Serotonin; Tetrabenazine; Torticollis	1977
Determination of 3-methoxy-4-hydroxyphenylpyruvic acid, 3,4-dihydroxyphenylethylene glycol, and 3,4-dihydroxyphenylmandelic acid in urine by mass fragmentography, with use of deuterium-labeled internal standards. Clinical chemistry, 1978, Volume: 24, Issue:11 Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Catechols; Child; Child, Preschool; Deuterium; Dopamine; Ethylene Glycols; Gas Chromatography-Mass Spectrometry; Humans; Infant; Infant, Newborn; Levodopa; Mandelic Acids; Methoxyhydroxyphenylglycol; Middle Aged; Neuroblastoma; Parkinson Disease; Phenylpyruvic Acids; Pheochromocytoma; Reference Standards; Reference Values; Shock, Cardiogenic	1978
Serum dopamine-beta-hydroxylase in parkinsonism. Journal of neural transmission, 1977, Volume: 40, Issue:1 Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Dopamine beta-Hydroxylase; Humans; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease	1977
Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome. Journal of neural transmission, 1977, Volume: 41, Issue:4 Topics: Brain Chemistry; Glycols; Humans; Hypothalamus; Levodopa; Methoxyhydroxyphenylglycol; Norepinephrine; Nucleus Accumbens; Parkinson Disease; Red Nucleus; Thalamus	1977
Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type. Journal of neural transmission. Parkinson's disease and dementia section, 1992, Volume: 4, Issue:3 Topics: Adult; Aged; Alzheimer Disease; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropeptide Y; Norepinephrine; Parkinson Disease; Peripheral Nervous System Diseases; Severity of Illness Index; Shy-Drager Syndrome; Spinal Cord Diseases	1992
Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material. Acta neuropathologica, 1992, Volume: 83, Issue:4 Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Astrocytoma; Biopsy; Catecholamines; Caudate Nucleus; Child; Dopamine; Female; Glioma; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Microscopy, Electron; Middle Aged; Norepinephrine; Parkinson Disease; Serotonin	1992
Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia. Advances in neurology, 1990, Volume: 53 Topics: Dystonia Musculorum Deformans; Enkephalin, Methionine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Neuropeptides; Neurotransmitter Agents; Parkinson Disease; Shy-Drager Syndrome; Somatostatin	1990
The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPS, HIAA, and HVA levels of cerebrospinal fluid. Advances in neurology, 1990, Volume: 53 Topics: Carboxy-Lyases; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Selegiline	1990
Behavioral recovery from MPTP-induced parkinsonism in monkeys after intracerebral tissue implants is not related to CSF concentrations of dopamine metabolites. Progress in brain research, 1990, Volume: 82 Topics: Adrenal Medulla; Amnion; Animals; Brain Tissue Transplantation; Caudate Nucleus; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Female; Fetal Tissue Transplantation; Graft Survival; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Male; Mesencephalon; Methoxyhydroxyphenylglycol; MPTP Poisoning; Parkinson Disease; Transplantation, Autologous; Transplantation, Heterotopic; Transplantation, Homologous	1990
The threshold of pain and neurotransmitter's change on pain in Parkinson's disease. The Japanese journal of psychiatry and neurology, 1990, Volume: 44, Issue:3 Topics: Aged; beta-Endorphin; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Nociceptors; Pain; Pain Measurement; Paresthesia; Parkinson Disease; Sensation; Sensory Thresholds	1990
[Development of a liquid chromatography/multiple electrochemical detector (LCMC) and its application in neuroscience]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1991, Volume: 97, Issue:2 Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Electrochemistry; Male; Methoxyhydroxyphenylglycol; Parkinson Disease; Rats; Rats, Inbred Strains; Tremor; Vanilmandelic Acid	1991
Clinical and biochemical features of depression in Parkinson's disease. The American journal of psychiatry, 1986, Volume: 143, Issue:6 Topics: Aged; Depressive Disorder; Dexamethasone; Growth Hormone; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Prolactin; Psychomotor Performance; Self Concept; Thyrotropin-Releasing Hormone	1986
Depression and Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Depressive Disorder; Dexamethasone; Growth Hormone; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Parkinson Disease; Prolactin; Thyrotropin-Releasing Hormone	1987
Clinical and biochemical correlates of bradyphrenia in Parkinson's disease. Neurology, 1987, Volume: 37, Issue:7 Topics: Aged; Alzheimer Disease; Arousal; Attention; Biogenic Amines; Cognition Disorders; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Parkinson Disease	1987
Diminished levels of ventricular fluid norepinephrine metabolite and somatostatin in childhood-onset dystonia. Advances in neurology, 1988, Volume: 50 Topics: Adolescent; Adult; Age Factors; Cerebral Palsy; Child; Child, Preschool; Dystonia; Homovanillic Acid; Humans; Hydrocephalus; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Multiple Sclerosis; Norepinephrine; Parkinson Disease; Somatostatin	1988
Unresponsiveness to L-DOPA in parkinsonian patients: a study of homovanillic acid concentration in the cerebrospinal fluid. Journal of the neurological sciences, 1989, Volume: 92, Issue:1 Topics: Aged; Biomarkers; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Parkinson Disease	1989
The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPG, HIAA and HVA levels in the cerebrospinal fluid. Acta neurologica Scandinavica. Supplementum, 1989, Volume: 126 Topics: Benserazide; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Glycols; Homovanillic Acid; Humans; Hydrazines; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Motor Activity; Parkinson Disease; Phenethylamines; Selegiline	1989
CSF monamine metabolites in movement disorders and normal aging. Archives of neurology, 1985, Volume: 42, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Dyskinesia, Drug-Induced; Dystonia; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Phenylacetates	1985
The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The New England journal of medicine, 1985, May-30, Volume: 312, Issue:22 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Substance-Related Disorders; Substantia Nigra; Syndrome	1985
CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease. Archives of neurology, 1985, Volume: 42, Issue:5 Topics: Adult; Aged; Alzheimer Disease; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Phenylacetates; Probenecid	1985
Catecholamines in CSF, plasma, and tissue after autologous transplantation of adrenal medulla to the brain in patients with Parkinson's disease. The Journal of laboratory and clinical medicine, 1989, Volume: 114, Issue:2 Topics: Adrenal Medulla; Adult; Catecholamines; Caudate Nucleus; Dopamine; Epinephrine; Homovanillic Acid; Humans; Infant, Newborn; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Parkinson Disease; Transplantation, Autologous	1989
Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease. Journal of the neurological sciences, 1986, Volume: 73, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Droxidopa; Drug Therapy, Combination; Glycols; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Parkinson Disease; Serine	1986
Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleus. Neurology, 1987, Volume: 37, Issue:1 Topics: Aged; Aged, 80 and over; Brain; Dementia; Desipramine; Dopamine; Homovanillic Acid; Humans; Locus Coeruleus; Methoxyhydroxyphenylglycol; Norepinephrine; Parkinson Disease; Yohimbine	1987
Correlation of autonomic dysfunction to CSF concentrations of noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's disease. European neurology, 1987, Volume: 26, Issue:1 Topics: Aged; Autonomic Nervous System Diseases; Glycols; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Parkinson Disease	1987
Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid. Journal of neurochemistry, 1973, Volume: 21, Issue:3 Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Carbon Radioisotopes; Cerebrospinal Fluid; Child; Chromatography, Gas; Dihydroxyphenylalanine; Dopamine; Down Syndrome; Dystonia Musculorum Deformans; Female; Glycols; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Methyltyrosines; Middle Aged; Norepinephrine; Parkinson Disease; Picolinic Acids; Probenecid; Serotonin; Spinal Cord Diseases; Time Factors	1973
Dopa, 3-O-methyldopa, and metabolites in urine during oral L-3-O-methyldopa therapy. Clinical pharmacology and therapeutics, 1974, Volume: 16, Issue:5 Part 1 Topics: Administration, Oral; Autoanalysis; Catecholamines; Dealkylation; Decarboxylation; Dihydroxyphenylalanine; Fluorometry; Homovanillic Acid; Humans; Lactates; Male; Methoxyhydroxyphenylglycol; Methyldopa; Parkinson Disease; Vanilmandelic Acid	1974